These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20116035)

  • 21. Acute stroke management.
    Ducharme J; Currie T; Ovens H; Rutledge T; Thompson J
    Can Fam Physician; 2001 Dec; 47():2458. PubMed ID: 11785275
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 23. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus.
    Levi CR; ; ;
    Med J Aust; 2004 Jun; 180(12):634-6. PubMed ID: 15200362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of fibrinolytic agents during surgical treatment for submacular hemorrhages of various etiology].
    Sosnovskiĭ VV; Sdobnikova SV
    Vestn Oftalmol; 2008; 124(6):47-51. PubMed ID: 19205404
    [No Abstract]   [Full Text] [Related]  

  • 25. Predicted impact of intravenous thrombolysis. Another trial is needed.
    Hoffman JR
    BMJ; 2000 Apr; 320(7240):1007. PubMed ID: 10809554
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Walsh M; Fromm G
    Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolysis 2004: the good, the bad, and the ugly.
    Caplan LR
    Rev Neurol Dis; 2004; 1(1):16-26. PubMed ID: 16397447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 30. Hope on the horizon for stroke patients.
    Cornell DH
    N J Med; 1998 Apr; 95(4):61-3. PubMed ID: 16010797
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alteplase treatment for acute stroke 2007: an effective therapeutic option at our disposal].
    Carneado-Ruiz J; Saver JL
    Rev Neurol; 2007 Jul 1-15; 45(1):42-52. PubMed ID: 17620265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteplase for acute stroke revisited: the first 10 years.
    Lyden PD; Lees KR; Davis SM
    Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
    [No Abstract]   [Full Text] [Related]  

  • 34. Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit.
    Saver JL; Gornbein J; Starkman S
    Stroke; 2010 Oct; 41(10):2381-90. PubMed ID: 20829518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Litigation regarding tPA and stroke.
    Pilcher CA
    Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 38. Old drugs, new tricks: update on stroke therapeutics.
    Fagan SC
    Rev Neurol Dis; 2010; 7 Suppl 1():S1-2; quiz S23. PubMed ID: 20410865
    [No Abstract]   [Full Text] [Related]  

  • 39. Alteplase for stroke. American Heart Association explains how guidelines were formulated.
    Faxon D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092606
    [No Abstract]   [Full Text] [Related]  

  • 40. Alteplase for stroke. Patients and doctors are being misled by promotional pressures.
    Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.